Details of the Drug Reposition

General Information of This Drug (ID: DMP1ZF8)

Drug Name
IC9-CAR19 cells   DMP1ZF8
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 1 [1]
Immunoproliferative disorder DISKM0P1 2B32 Phase 1 [1]
Immune System disease DISPV68Z 4A01-4B41 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03016377) Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia